Herbert W. Boyer & Stanley N. Cohen
Inventors of Plasmid Molecular Cloning; inserted foreign recombinant DNA into bacterial plasmids (pSC101) to clone and express recombinant proteins, co-founding Genentech.
Nobel Prize Recognition
National Medal of Science (1990 to Boyer, 1988 to Cohen), Shaw Prize (2004)
We realized that the ability to splice any gene into a plasmid and propagate it in bacteria meant that biology would never be the same again.
Curiosity & Historical Discovery Anecdote
The serendipity, obstacles, and fascinating human journey behind the discovery.
Boyer and Cohen conceived their revolutionary plasmid cloning partnership over midnight corned beef and pastrami sandwiches at a delicatessen in Honolulu, Hawaii, in November 1972 while attending a joint US-Japan conference on bacterial plasmids! In 1976, venture capitalist Robert Swanson met Boyer for what was planned as a 20-minute beer meeting; they ended up drinking for three hours and shaking hands to found Genentech, the world's first biotechnology company.
High-Yield Exam Focus (CSIR-NET, GATE, USMLE)
Core mechanisms, experimental controls, and recurring competitive exam questions.
The Cohen-Boyer Plasmid Cloning System (1973): (1) Cleave plasmid vector (pSC101, conferring tetracycline resistance) and target foreign DNA with EcoRI restriction endonuclease, producing complementary 4-bp sticky ends (5'-AATT-3'); (2) Ligate plasmid and insert using T4 DNA Ligase; (3) Transform calcium chloride (CaCl2) heat-shock competent E. coli cells; (4) Select recombinant transformants on antibiotic agar plates. Expressed human somatostatin (1977) and recombinant human insulin (Humulin, 1978).
Landmark Scientific Breakthroughs & Molecular Mechanisms
Step-by-step scientific explanations of the discoveries that defined modern biology.
Invention of Plasmid-Based Molecular Cloning and Gene Splicing
Experimental Logic & Mechanism:
Digested the small antibiotic-resistance plasmid pSC101 and foreign DNA fragments with EcoRI restriction enzyme (isolated in Boyer's UCSF lab), generating matching cohesive overhangs. Annealed and ligated the hybrid molecules with DNA ligase and introduced them into calcium-treated E. coli, demonstrating stable plasmid replication, expression of foreign phenotypic antibiotic resistance, and inter-species cloning (Xenopus ribosomal genes into bacteria).
Production of Recombinant Human Insulin and Founding of Genentech
Experimental Logic & Mechanism:
Co-founded Genentech with Robert Swanson. Synthesized cDNA encoding the A and B chains of human insulin, cloned them into expression plasmids downstream of the beta-galactosidase promoter in E. coli, and chemically reconstituted functional active human insulin in vitro (Humulin).
Biographical Journey & Intellectual Legacy
Chronological chronicle of early education, mentorship, research trials, and achievements.
Herbert Wayne Boyer was born in Derry, Pennsylvania. He earned his bachelor's from Saint Vincent College in 1958 and his PhD in bacteriology from the University of Pittsburgh in 1963 under Paul Ellis. Joining UCSF in 1966, he discovered EcoRI restriction endonuclease.
Stanley Norman Cohen was born in Perth Amboy, New Jersey. Educated at Rutgers and the University of Pennsylvania medical school, he joined Stanford University School of Medicine in 1968, discovering how to introduce antibiotic resistance plasmids into E. coli via calcium chloride transformation.
Their collaboration began in Honolulu in 1972, culminating in their historic 1973 PNAS paper announcing plasmid cloning.
Stanford and UCSF jointly patented the Cohen-Boyer technique in 1980; licensed non-exclusively to hundreds of pharmaceutical companies, it generated hundreds of millions of dollars in university research royalties.
Boyer served as Vice President of Genentech until 1990. Both Boyer and Cohen received the National Medal of Science, the Lemelson-MIT Prize, and the Albany Medical Center Prize, remaining revered pioneers of the biotechnology age.
Landmark Publications & Primary Literature
Original monographs and communications that announced the breakthroughs to the world.
Cohen, S. N., Chang, A. C., Boyer, H. W., & Helling, R. B. (1973). Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy of Sciences, 70(11), 3240-3244.
Significance: The historic paper reporting the invention of recombinant DNA plasmid cloning.
Morrow, J. F., Cohen, S. N., Chang, A. C., Boyer, H. W., Goodman, H. M., & Helling, R. B. (1974). Replication and transcription of eukaryotic DNA in Escherichia coli. Proceedings of the National Academy of Sciences, 71(5), 1743-1747.
Significance: Demonstrated inter-kingdom gene expression by cloning frog (Xenopus) genes into bacterial plasmids.
Explore Related Lecture Notes on B10logy
Direct access to comprehensive textbook notes where these discoveries are analyzed in depth.